Key terms

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VRTX news

Yesterday 2:05pm ET Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study by TipRanks Yesterday 7:40am ET Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN) by TipRanks Apr 12 11:08am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 12 10:55am ET Vertex Pharmaceuticals’ Hold Rating: Balancing Cystic Fibrosis Success with Uncertain Growth from New Acquisition by TipRanks Apr 12 1:41am ET Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS) by TipRanks Apr 12 1:40am ET Buy Rating Affirmed: Vertex Pharmaceuticals’ Strategic Acquisition and Market Positioning Promise Growth by TipRanks Apr 12 1:37am ET Analyst Maintains ‘Sell’ Rating on Vertex Pharmaceuticals Amid Skepticism Over Alpine Acquisition and Early-Stage Data by TipRanks Apr 11 7:48pm ET Alpine Immune Sciences downgraded to Market Perform from Outperform at Leerink by TipRanks Apr 11 10:49am ET Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition by TipRanks Apr 11 9:40am ET DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls by TipRanks Apr 11 8:43am ET Vertex Pharmaceuticals price target raised to $462 from $457 at H.C. Wainwright by TipRanks Apr 11 6:34am ET Evercore expects Vera Therapeutics to trade up on Alpine acquisition news by TipRanks Apr 11 6:26am ET Vertex Pharmaceuticals upgraded to Outperform from In Line at Evercore ISI by TipRanks Apr 11 6:23am ET Drugmakers look to alternative suppliers after draft U.S. legislation, FT says by TipRanks Apr 11 5:10am ET Alpine Immune downgraded to Sector Perform from Outperform at RBC Capital by TipRanks Apr 10 4:02pm ET Vertex to acquire Alpine Immune Sciences for $65 per share by TipRanks Apr 08 10:30pm ET Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Vertex Pharmaceuticals (VRTX) and Korro Bio (KRRO) by TipRanks Apr 08 10:07am ET RBC says pain opinion leader ‘notably negative’ on Vertex’s VX-548 by TipRanks Apr 03 9:25am ET Truist pharmaceuticals analyst holds an analyst/industry conference call by TipRanks Apr 03 4:55am ET Truist pharmaceuticals analyst holds an analyst/industry conference call by TipRanks Apr 02 7:25am ET Truist Financial Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX) by TipRanks Apr 02 7:20am ET Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX) by TipRanks Apr 02 5:31am ET Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Vertex Pharmaceuticals (VRTX) and Veeva Systems (VEEV) by TipRanks Apr 01 11:04am ET Vertex announces acceptance of NDS for exagamglogene autotemcel by TipRanks Apr 01 8:10am ET Vertex Pharmaceuticals advances inaxaplin into Phase 3 portion of trial by TipRanks Mar 31 10:29pm ET Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)? by TipRanks Mar 28 1:29pm ET Truist pharmaceuticals analyst holds an analyst/industry conference call by TipRanks Mar 22 7:16am ET Analyst Issues Sell Rating for Vertex Pharmaceuticals Amid Intensifying Drug Market Competition by TipRanks Mar 21 8:04am ET Vertex Pharmaceuticals announces FDA clearance of VX-407 IND by TipRanks Mar 15 11:15am ET William Blair biotech analysts to hold an analyst/industry conference call by TipRanks Mar 15 4:55am ET William Blair biotech analysts to hold an analyst/industry conference call by TipRanks

No recent press releases are available for VRTX

VRTX Financials

1-year income & revenue

Key terms

VRTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VRTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments